Carcinomas of the uterine cervix are the most common cancer of the female genital tract among females ages 15-29. In 2006, it was noted that the 5-year overall survival rates for cervical cancer had not improved over the previous 25 years for this age group. Cervical cancer occurs more often in females infected with certain types of human papilloma virus (HPV). Cervical cancer is one of the few cancers that can be identified early in the 15-29 year range through proper screening methods such as pap smears. Improved screening programs and the development of the HPV vaccine may prevent the development of invasive cervical cancers in the future.
Source: Bleyer A, O’Leary M, Barr R, Ries LAG (eds): Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD 2006. http://seer.cancer.gov/publications/aya/
The Effect of Country of Birth on the Pattern of Disease and Survival From Cervical Cancer.
J Low Genit Tract Dis. 2016 Jan;20(1):38-43
Authors: Moss E, Askew S, Cheung S, Dawson P, Singh K, Redman CW,...
Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population.
J Low Genit Tract Dis. 2016 Jan;20(1):26-30
Authors: Spiryda LB, Whitaker KM,...
Using probabilistic record linkage methods to identify Australian Indigenous women on the Queensland Pap Smear Register: the National Indigenous Cervical Screening Project.
BMJ Open. 2016 Feb 12;6(2):e009540...
Surveillance of effects of HPV vaccination in Belgium.
Cancer Epidemiol. 2016 Apr;41:152-8
Authors: Arbyn M, Broeck DV, Benoy I, Bogers J, Depuydt C, Praet M, Sutter PD, Hoorens A, Hauben E, Poppe W, Van Ranst M, Delvenne P, Gofflot S, Pétein M, Engelen F, Vanneste A, Beeck LO...
Use of claims data to estimate annual cervical cancer screening percentages in Portland metropolitan area, Oregon.
Cancer Epidemiol. 2016 Apr;41:106-12
Authors: Abdullah N, Laing RS, Hariri S, Young CM, Schafer S
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
BMC Cancer. 2016 Feb 20;16:132
Authors: Koeneman MM, Kruse...
Cervical Cancer in Women Aged 35 Years and Younger.
Clin Ther. 2016 Mar;38(3):459-66
Authors: Pelkofski E, Stine J, Wages NA, Gehrig PA, Kim KH, Cantrell LA
PURPOSE: Age has been evaluated as a prognostic factor in cervical cancer in both...
Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life.
Clin Ther. 2016 Mar;38(3):467-75
Authors: Iyer NS, Osann K, Hsieh S, Tucker JA, Monk BJ, Nelson EL, Wenzel L
PURPOSE: Improvement in health behaviors...
Evaluation of Human Papillomavirus as a Risk Factor for Preterm Birth or Pregnancy-Related Hypertension.
Obstet Gynecol. 2016 Feb;127(2):233-40
Authors: Subramaniam A, Lees BF, Becker DA, Tang Y, Khan...
Reproductive and genital health and risk of cervical human papillomavirus infection: results from the Ludwig-McGill cohort study.
BMC Infect Dis. 2016 Mar 08;16:116
Authors: Shaw E, Ramanakumar AV...
The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study.
Cancer Causes Control. 2016 Apr;27(4):569-81
Authors: Naber SK, de Kok IM, Matthijsse SM, van Ballegooijen M...
Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria.
BMC Infect Dis. 2016 Apr 16;16:153
Authors: Boiron L, Joura E, Largeron N,...